David Evans
About David Evans
David Evans serves as the Senior Director of Intellectual Property at Ardelyx, Inc., a position he has held since 2017. He has extensive experience in intellectual property, having worked at various companies including Genentech and Agios Pharmaceuticals.
Work at Ardelyx
David Evans has served as the Senior Director of Intellectual Property at Ardelyx, Inc. since 2017. In this role, he is responsible for overseeing the company's intellectual property strategy and managing patent portfolios. His tenure at Ardelyx, based in Fremont, California, has spanned seven years, contributing to the company's focus on developing innovative therapies.
Previous Experience in Intellectual Property
Before joining Ardelyx, David Evans held several significant positions in the field of intellectual property. He worked at Genentech as a Principal Patent Agent and Director from 2000 to 2011, where he gained extensive experience in patent management. He also served as Senior Director of Intellectual Property at Elan from 2011 to 2013, further solidifying his expertise in the sector.
Career Background
David Evans began his career as a Patent Analyst at Elan from 1991 to 1995. He later transitioned to Genentech, where he spent eleven years. In addition to his roles at Ardelyx and Genentech, he was a member of the Board of Directors at Cyprotex from 2004 to 2009. His diverse background includes significant roles in various companies across North America and Europe.
Education and Expertise
David Evans studied at the University of Toronto, where he developed a solid foundation in intellectual property law and patent management. His educational background supports his extensive experience in the field, enabling him to navigate complex patent issues effectively throughout his career.